# Arbutus Biopharma Corporation (ABUS) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$38M |
| 2024 | -$76M |
| 2023 | -$78M |
| 2022 | -$65M |
| 2021 | -$74M |
| 2020 | -$58M |
| 2019 | -$144M |
| 2018 | -$90M |
| 2017 | -$111M |
| 2016 | -$492M |
| 2015 | -$104M |
| 2014 | -$33M |
| 2013 | -$12M |
| 2012 | -$13M |
| 2011 | -$11M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | $169M |
| 2025-09-30 | -$9M |
| 2025-06-30 | $1M |
| 2025-03-31 | -$26M |
| 2024-09-30 | -$21M |
| 2024-06-30 | -$22M |
| 2024-03-31 | -$19M |
| 2023-09-30 | -$22M |
| 2023-06-30 | -$18M |
| 2023-03-31 | -$17M |
| 2022-09-30 | -$18M |
| 2022-06-30 | -$14M |
| 2022-03-31 | -$11M |
| 2021-09-30 | -$18M |
| 2021-06-30 | -$19M |
| 2021-03-31 | -$16M |
| 2020-09-30 | -$15M |
| 2020-06-30 | -$13M |
| 2020-03-31 | -$13M |
| 2019-09-30 | -$91M |
| 2019-06-30 | -$21M |
| 2019-03-31 | -$19M |
| 2018-09-30 | -$32M |
| 2018-06-30 | -$22M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/ABUS/operating-income)